Sign in / Join Now
ETFs & Funds
Using AVIIs RNA tech, they have the potential to tx even drug resistant TB. I hope officials in India know about
before it is too late.
Just curious, why do you never respond to anyone's questions? with all of your knowledge and insight, I would think you would be proud
I like your knowledge in the field, but it's useless if you do not respond to fellow investors. You get called out on the PUMP
Add a reply...
Latest StockTalks »
people get SRPT breaking news and analysis by email alert.
Get email alerts on SRPT »
Sarepta Therapeutics, Inc.
Get latest price
From other sites
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
at TheStreet (Nov 30, 2016)
Sarepta Therapeutics Enters Oversold Territory (SRPT)
at Nasdaq.com (Nov 30, 2016)
Commit To Purchase Sarepta Therapeutics At $20, Earn 18% Using Options
at Nasdaq.com (Nov 22, 2016)
3 Reasons 2017 Launch Expectations For Sarepta's EXONDYS 51 Are 'Too High'
at Benzinga (Nov 11, 2016)
Sarepta Therapeutics To Present Company Overview At The Credit Suisse 25th Annual Healthcare Conference
at TheStreet (Nov 4, 2016)